Update

$Viracta Therapeutics (VIRX.US)$ Viracta Therapeutics Announces Positive Data From the Phase 2 Naval-1 Trial, Regulatory Progress, and Updated Nana-Val Clinical Development Plan

免責聲明：社區由Moomoo Technologies Inc.提供，僅用於教育目的。更多信息